{"id":8218,"date":"2020-09-10T05:11:06","date_gmt":"2020-09-10T10:11:06","guid":{"rendered":"https:\/\/cornflowerblue-rail-980953.hostingersite.com\/?p=8218"},"modified":"2020-09-10T05:11:06","modified_gmt":"2020-09-10T10:11:06","slug":"whats-new-in-liver-imaging-turkish-september-2020","status":"publish","type":"post","link":"https:\/\/staging-hub.acoredu.com\/tr\/whats-new-in-liver-imaging-turkish-september-2020\/","title":{"rendered":"What’s new in Liver Imaging (Turkish) – September 2020"},"content":{"rendered":"

HCC <\/strong><\/span><\/h3>\n

 <\/p>\n

Hepatosel\u00fcler Karsinomda \u00a0LI-RADS Tedavi Yan\u0131t Algoritmas\u0131n\u0131n Tan\u0131sal Performans\u0131: BT ve MRG’deki Kontrastlanma Paternleriyle Kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda MRG’ye Yard\u0131mc\u0131 \u00d6zellikler Ekleme<\/span> <\/strong><\/h5>\n

Park, S., Joo, I., Lee, D. H., Bae, J. S., Yoo, J., Kim, S. W., & Lee, J. M. (2020).<\/p>\n

Diagnostic performance of LI-RADS treatment response algorithm for hepatocellular carcinoma: adding ancillary features to MRI compared with enhancement patterns at CT and MRI. Radiology, 192797.<\/p>\n

https:\/\/doi.org\/10.1148\/radiol.2020192797<\/a><\/p>\n

Klinik soru:<\/strong> Kategori ayarlamas\u0131nda MRI yard\u0131mc\u0131 \u00f6zelliklerinin tan\u0131sal performans\u0131n\u0131, t\u00fcm\u00f6r canl\u0131l\u0131\u011f\u0131n\u0131 saptamak i\u00e7in BT ve MRI’daki LR-TR algoritmas\u0131 ile kar\u015f\u0131la\u015ft\u0131rmak.<\/p>\n

Nas\u0131l Yap\u0131ld\u0131:<\/strong> 2014 ve 2017 y\u0131llar\u0131 aras\u0131nda, HCC tan\u0131s\u0131 koyulmus, LRT(lokorejyonel) tedavi g\u00f6rm\u00fc\u015f ve ard\u0131ndan cerrahi rezeksiyon veya karaciger transplantasyonu yap\u0131lm\u0131\u015f 138 hastan\u0131n retrospektif \u00e7al\u0131\u015fmas\u0131.<\/p>\n

Bulgular ve Sonu\u00e7lar:<\/strong> BT LR-TR canl\u0131l\u0131k ve MRG LR-TR canl\u0131l\u0131k kategorilerinin t\u00fcm\u00f6r canl\u0131l\u0131\u011f\u0131n\u0131 tahmin y\u00fczdesi duyarliligi %73\u2019e %76 iken \u00f6zg\u00fcll\u00fc\u011f\u00fc %90\u2019a %83 olmu\u015ftur. MR ile modifiye edilmi\u015f TR canl\u0131l\u0131k kategorisi, \u00f6zg\u00fcll\u00fckte farkl\u0131l\u0131k olmaks\u0131z\u0131n, BT veya MRI LR-TR canl\u0131l\u0131k kategorisinden daha y\u00fcksek duyarl\u0131l\u0131\u011fa (% 84) sahiptir.<\/p>\n

Sonu\u00e7:<\/strong> MRI yardimci ozelliklerinin LI-RADS TR algoritmas\u0131na uygulanmas\u0131, patolojik t\u00fcm\u00f6r canl\u0131l\u0131\u011f\u0131n\u0131n tahmininde tek ba\u015f\u0131na BT veya MRI modellerine k\u0131yasla \u00f6zg\u00fcll\u00fckte de\u011fi\u015fiklik \u00a0olmaks\u0131z\u0131n daha y\u00fcksek duyarl\u0131l\u0131k sa\u011flad\u0131.<\/p>\n

\u00c7\u0131kar\u0131mlar:<\/strong> LI-RADS-TR algoritmas\u0131n\u0131n MRI yard\u0131mc\u0131 \u00f6zelliklerinin eklenmesiyle artan duyarl\u0131l\u0131\u011f\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, LI-RADS’nin sonraki g\u00fcncellemeleri daha iyi tan\u0131sal do\u011fruluk i\u00e7in MRI yard\u0131mc\u0131 \u00f6zelliklerinin iste\u011fe ba\u011fl\u0131 kullan\u0131m\u0131n\u0131 i\u00e7erebilir.<\/p>\n

\u00a0<\/strong><\/p>\n

Gadoksetik Asitle G\u00fc\u00e7lendirilmi\u015f MRG’de LR-4’ten LR-5’e Y\u00fckseltmek \u0130\u00e7in Karaci\u011fer G\u00f6r\u00fcnt\u00fcleme Raporlama ve Veri Sistemi Versiyon 2018 Yard\u0131mc\u0131 \u00d6zelliklerinin Uygulanmas\u0131<\/span> <\/strong><\/h5>\n

Lee S, Kim SS, Bae H, Shin J, Yoon JK, Kim MJ.<\/p>\n

Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI [published online ahead of print, 2020 Aug 18]. Eur Radiol. 2020;10.1007\/s00330-020-07146-4.<\/p>\n

https:\/\/doi.org\/10.1007\/s00330-020-07146-4<\/a><\/p>\n

Anahtar Kelimeler:<\/strong> Kontrast madde; Tan\u0131; Karaci\u011fer neoplazileri; Manyetik rezonans g\u00f6r\u00fcnt\u00fcleme; Duyarl\u0131l\u0131k ve \u00f6zg\u00fcll\u00fck.<\/p>\n

Klinik Soru:<\/strong> LR-4’\u00fc LR-5’e y\u00fckseltmek i\u00e7in MRG\u2019de yard\u0131mc\u0131 \u00f6zellikleri kullanabilir miyiz?<\/p>\n

Ne yap\u0131ld\u0131:<\/strong> Y\u00fckseltilmi\u015f LR-5’in (yard\u0131mc\u0131 \u00f6zelllikler kullan\u0131larak) tan\u0131sal performans\u0131, standart LR-5 kategorisi ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131.<\/p>\n

Nas\u0131l yap\u0131ld\u0131:<\/strong> 2015 ve 2017 y\u0131llar\u0131 aras\u0131nda Gd-MRI yap\u0131lan, HCC i\u00e7in y\u00fcksek riskli 280 hastan\u0131n retrospektif \u00e7al\u0131\u015fmas\u0131. Ba\u011f\u0131ms\u0131z olarak \u00f6nemli yard\u0131mc\u0131 \u00f6zellikler belirlendi. Y\u00fckseltilmi\u015f LR-5 kriteri, ba\u011f\u0131ms\u0131z \u00f6nemli yard\u0131mc\u0131 \u00f6zellikler ile major \u00f6zellikler taraf\u0131ndan belirlenen LR-4\u2019\u00fcn birle\u015ftirilmesiyle olu\u015fturuldu. Tan\u0131 kriterlerinin duyarl\u0131l\u0131klar\u0131 ve \u00f6zg\u00fcll\u00fckleri kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131.<\/p>\n

Bulgular ve Sonuclar:<\/strong> D\u00f6rt yardimci ozellik (hafif-orta T2 hiperintensitesi, hepatobiliyer faz hipointensitesi, boyanmayan “kaps\u00fcl” ve mozaik yap\u0131), HCC tan\u0131s\u0131nda ba\u011f\u0131ms\u0131z \u00f6nemli \u00f6zelliklerdi. Y\u00fckseltilmi\u015f LR-5 kriterlerini kullanarak, standart LR-5’e (% 66,2) k\u0131yasla duyarl\u0131l\u0131k \u00f6nemli \u00f6l\u00e7\u00fcde artm\u0131\u015ft\u0131r (% 69,4-76,9), ancak \u00f6zg\u00fcll\u00fckte \u00f6nemli farkl\u0131l\u0131k saptanmam\u0131\u015ft\u0131r.<\/p>\n

Karar:<\/strong> Ba\u011f\u0131ms\u0131z \u00f6nemli yard\u0131mc\u0131 \u00f6zellikler, Gd-MRI’da \u00f6zg\u00fcll\u00fc\u011f\u00fc de\u011fi\u015ftirmeden duyarl\u0131l\u0131\u011f\u0131 art\u0131rmak i\u00e7in LR-4’ten LR-5’e y\u00fckseltmek i\u00e7in kullan\u0131labilir.<\/p>\n

\u00c7\u0131kar\u0131mlar:<\/strong> LI-RADS’nin ilk \u00e7\u0131k\u0131\u015f\u0131ndan bu yana, LR-5 kategorisi yaln\u0131zca ana \u00f6zelliklere g\u00f6re belirlenmi\u015ftir ve yard\u0131mc\u0131 \u00f6zellikler, HCC\u2019de LR-5’in y\u00fcksek \u00f6zg\u00fcll\u00fc\u011f\u00fcn\u00fc korumak amac\u0131yla LR-4’\u00fc LR-5’e y\u00fckseltmek i\u00e7in kullan\u0131lamaz. Bu geriye d\u00f6n\u00fck \u00e7al\u0131\u015fma, belirli yard\u0131mc\u0131 \u00f6zelliklerin duyarl\u0131l\u0131\u011f\u0131 art\u0131r\u0131p \u00f6zg\u00fcll\u00fc\u011f\u00fc koruyarak LR-4’\u00fc y\u00fckseltmek i\u00e7in kullan\u0131labilece\u011fine dair kan\u0131t sa\u011fl\u0131yor.<\/p>\n

 <\/p>\n

KARAC\u0130\u011eER G\u00d6R\u00dcNT\u00dcLEME TEKN\u0130KLER\u0130<\/strong><\/span><\/h3>\n

\u00a0<\/strong><\/p>\n

Y\u00fcksek Riskli Bireylerde Hepatosel\u00fcler Karsinom Tan\u0131s\u0131nda S\u00fclf\u00fcr Heksaflor\u00fcr ve Perflorob\u00fctan ile Kontrastl\u0131 Ultrason<\/span> <\/strong><\/h5>\n

Kang, H. J., Lee, J. M., Yoon, J. H., Lee, K., Kim, H., & Han, J. K. (2020).<\/p>\n

Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk. Radiology, 200115.<\/p>\n

Advance online publication: https:\/\/doi.org\/10.1148\/radiol.2020200115<\/a><\/p>\n

Klinik Soru:<\/strong> Perflorob\u00fctan (PFB)\u2019l\u0131 ultrason, HCC te\u015fhisinde S\u00fclf\u00fcr Heksaflor\u00fcr (SHF)\u2019l\u00fc ultrasona \u00fcst\u00fcn m\u00fc?<\/p>\n

Ne yap\u0131ld\u0131:<\/strong> CEUS LI-RADS v2017’nin tan\u0131sal performans\u0131, kontrast madde olarak PFB ve SHF kullan\u0131larak kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131.<\/p>\n

Nas\u0131l yap\u0131ld\u0131:<\/strong> \u015e\u00fcpheli hepatic g\u00f6r\u00fcnt\u00fcleme bulgusu olan (LR-3, LR-4, LR-5 ve LR-M) ve ayn\u0131 g\u00fcn PFB\u2019li US ve SHF\u2019li US yap\u0131lan, HCC i\u00e7in y\u00fcksek riskli 59 hastan\u0131n prospektif \u00e7al\u0131\u015fmas\u0131. Kupffer faz\u0131ndakiarteryel kontrastlanma, wash-out zaman\u0131 ve derecesi ve ekojenite CEUS LI-RADS v2017 kullan\u0131larak de\u011ferlendirildi ve kategorize edildi. Her iki tekni\u011fin tan\u0131sal performans\u0131 kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131.<\/p>\n

Bulgular ve sonu\u00e7lar:<\/strong> Arteryel fazda kontrastlanma her iki kontrast madde ile ayn\u0131 \u015fekilde g\u00f6zlendi. PFB\u2019li ultrasonografi ile ge\u00e7 ve hafif wash-out daha s\u0131kt\u0131. HCC’ler i\u00e7in wash-out zaman\u0131 PFB\u2019li ultrasonografide, SHF\u2019li ultrasonografiye g\u00f6re daha ge\u00e7ti. Duyarl\u0131l\u0131k, PFB\u2019li \u00a0ultrasonografide (%79), SHF\u2019li ultrasonografiye (%54) g\u00f6re daha y\u00fcksekti. \u00d6zg\u00fcll\u00fck her ikisinde de %100 idi.<\/p>\n

Karar:<\/strong> PFB kullan\u0131lan CEUS LI-RADS, \u00f6zg\u00fcll\u00fck kayb\u0131 olmaks\u0131z\u0131n SHF’ye k\u0131yasla anlaml\u0131 olarak daha y\u00fcksek bir duyarl\u0131l\u0131\u011fa sahipti.<\/p>\n

\u00c7\u0131kar\u0131mlar:<\/strong> CEUS LI-RADS v2017 \u015fu anda SHF gibi saf kan havuzu ajanlar\u0131 i\u00e7in ge\u00e7erlidir ancak PFB gibi kombine kan havuzu\/Kupffer h\u00fccre ajanlar\u0131 i\u00e7in ge\u00e7erli de\u011fildir. PFB hen\u00fcz Amerika Birle\u015fik Devletleri’nde karaci\u011fer kullan\u0131m\u0131 i\u00e7in onaylanmam\u0131\u015f olsa da, geleneksel olarak kullan\u0131lan SHF’den daha iyi bir tan\u0131sal performans sa\u011flar. PFB\u2019li ultrasonografinin Amerika Birle\u015fik Devletleri’nde uygulanmas\u0131 yak\u0131n gelecekte gerekli olabilir.<\/p>\n

 <\/p>\n

Hepatosel\u00fcler Karsinom Tan\u0131s\u0131nda Kontrastl\u0131 Ultrason Karaci\u011fer G\u00f6r\u00fcnt\u00fcleme Raporlama ve Veri Sistemi: Bir Meta-Analiz<\/strong><\/span><\/h5>\n

Shin, J., Lee, S., Bae, H., Chung, Y. E., Choi, J. Y., Huh, Y. M., & Park, M. S. (2020).<\/p>\n

Contrast-enhanced ultrasound liver imaging reporting and data system for diagnosing hepatocellular carcinoma: A meta-analysis. Liver international: official journal of the International Association for the Study of the Liver, 10.1111\/liv.14617.<\/p>\n

Advance online publication: https:\/\/doi.org\/10.1111\/liv.14617<\/a><\/p>\n

Anahtar kelimeler:<\/strong> tan\u0131; karaci\u011fer neoplazmlar\u0131; mikrokabarc\u0131klar; duyarl\u0131l\u0131k ve \u00f6zg\u00fcll\u00fck; ultrason.<\/p>\n

Klinik soru:<\/strong> HCC\u2019de CEUS LR-5’in tan\u0131sal performans\u0131 nedir?<\/p>\n

Ne yap\u0131ld\u0131:<\/strong> CEUS LR-5’in tan\u0131sal performans\u0131 ve her CEUS LI-RADS kategorisindeki HCC oran\u0131 de\u011ferlendirildi.<\/p>\n

Nas\u0131l yap\u0131ld\u0131:<\/strong> 3983’\u00fc HCC, toplam 5535 g\u00f6r\u00fcnt\u00fcleme bulgusu i\u00e7eren 11 \u00e7al\u0131\u015fman\u0131n meta-analizi. Her bir CEUS LI-RADS kategorisinde HCC’lerin birle\u015ftirilmi\u015f oranlar\u0131n\u0131n ve CEUS LR-5 tan\u0131sal performans\u0131n\u0131n \u00f6zet tahminlerini belirlemek i\u00e7in rastgele etki modeli kullan\u0131lm\u0131\u015ft\u0131r. Taraf tutma riski ve uygulanabilirlikle ilgili endi\u015feler de\u011ferlendirildi.<\/p>\n

Bulgular ve sonu\u00e7lar:<\/strong> HCC tan\u0131s\u0131 i\u00e7in LR-5’in duyarl\u0131l\u0131\u011f\u0131 ve \u00f6zg\u00fcll\u00fc\u011f\u00fc s\u0131ras\u0131yla %69 ve %92 idi. HCC’lerin birle\u015ftirilmi\u015f oranlar\u0131 LR-1 i\u00e7in %0, LR-2 i\u00e7in %1, LR-3 i\u00e7in %26, LR-4 i\u00e7in %77, CEUS LR-5 i\u00e7in %97 ve LR-M i\u00e7in %57 idi.<\/p>\n

Karar:<\/strong> LR-5 kategori, HCC tan\u0131s\u0131nda orta derecede duyarl\u0131l\u0131k ve y\u00fcksek \u00f6zg\u00fcll\u00fck saptad\u0131.<\/p>\n

\u00c7\u0131kar\u0131mlar:<\/strong> CEUS LI-RADS, HCC tan\u0131s\u0131nda g\u00fcvenle kullan\u0131labilir.<\/p>\n

 <\/p>\n

KARAC\u0130\u011eER: TEMEL B\u0130L\u0130M<\/strong><\/span><\/h3>\n

\u00a0<\/strong><\/p>\n

K\u00f6peklerde Gd-EOB-DTPA MRG Kullanarak Hepatit ve Fibrozis De\u011ferlendirilmesi<\/strong><\/span><\/h5>\n

Tanaka, T., Nishida, H., Mie, K., Yamazaki, H., Lin, L. S., & Akiyoshi, H. (2020).<\/p>\n

Assessment of hepatitis and fibrosis using Gd-EOB-DTPA MRI in dogs. Veterinary record open, 7(1), e000371.<\/p>\n

https:\/\/doi.org\/10.1136\/vetreco-2019-000371<\/a><\/p>\n

Anahtar kelimeler:<\/strong> gadoksetat sodyum; hepatosel\u00fcler adenom; hepatosel\u00fcler karsinom; karaci\u011fer fonksiyonu; manyetik rezonans g\u00f6r\u00fcnt\u00fcleme (MRG); nod\u00fcler hiperplazi.<\/p>\n

Klinik soru:<\/strong> Gd-EOB-DTPA MRG kullanarak kontrast g\u00fc\u00e7lendirme k\u00f6peklerde karaci\u011fer fonksiyonu ile ili\u015fkili midir?<\/p>\n

Ne yap\u0131ld\u0131:<\/strong> Ana safra kanal\u0131 ve safra kesesinin r\u00f6latif sinyal intensiteleri (Relative Signal Intensities, RSI) hesapland\u0131 ve bunlar\u0131n karaci\u011fer fonksiyon biyokimyasal parametreleri ile ili\u015fkileri de\u011ferlendirildi. Karaci\u011ferin r\u00f6latif kontrastlanma indeksleri (Relative Contrast Enhancement Indices, RCEI) hesapland\u0131; normal ve hastal\u0131kl\u0131 karaci\u011fer aras\u0131ndaki farklar de\u011ferlendirildi.<\/p>\n

Nas\u0131l yap\u0131ld\u0131:<\/strong> Histolojik olarak kan\u0131tlanm\u0131\u015f karaci\u011fer hastal\u0131\u011f\u0131 olan 16 k\u00f6pe\u011fin retrospektif \u00e7al\u0131\u015fmas\u0131 (HCC, nod\u00fcler hiperplazi, hepatosel\u00fcler adenom, karaci\u011fer fibrozisi ve hepatit). Ana safra kanal\u0131 ve safra kesesinin r\u00f6latif sinyal yo\u011funluklar\u0131 hesapland\u0131. Karaci\u011ferdeki ortalama SI, hepatobiliyer faz s\u0131ras\u0131nda hesapland\u0131 ve temsili hepatik parankim sinyal intensitesi olarak kullan\u0131ld\u0131. Bu indeksler ile karaci\u011fer fonksiyon biyokimyasal belirte\u00e7leri aras\u0131ndaki ili\u015fki de\u011ferlendirildi. Bu belirte\u00e7ler toplam bilirubin, alanin transaminaz, alkalin fosfataz ve alb\u00fcminden olu\u015fuyordu.<\/p>\n

Bulgular ve sonu\u00e7lar:<\/strong> RSI, histopatolojik karaci\u011fer hastal\u0131\u011f\u0131 tan\u0131s\u0131 olan k\u00f6peklerde alb\u00fcmin (\u03c1=0.57) ile anlaml\u0131 bir \u015fekilde ili\u015fkili olmas\u0131na ra\u011fmen, histopatolojik karaci\u011fer tan\u0131s\u0131 olan ve olmayan k\u00f6pekler aras\u0131nda anlaml\u0131 bir fark g\u00f6stermedi. RCEI, normal karaci\u011fer dokusunda hepatit\/fibrozisli ve HCC’li karaci\u011ferlerden anlaml\u0131 olarak daha y\u00fcksekti ancak nod\u00fcler hiperplazi\/hepatosel\u00fcler adenomda de\u011fildi.<\/p>\n

Karar:<\/strong> Karaci\u011fer hastal\u0131\u011f\u0131 olan k\u00f6peklerde ana safra kanal\u0131 ve safra kesesinin RSI’s\u0131 alb\u00fcminden etkilenir. Normal karaci\u011ferde hepatobiliyer fazdaki RCEI, hepatit ve fibrozisten daha y\u00fcksektir.<\/p>\n

\u00c7\u0131kar\u0131mlar:<\/strong> Gd-EOB-DTPA MRG, k\u00f6peklerde hepatit ve hepatik fibrozisin de\u011ferlendirilmesinde yararl\u0131 olabilir.<\/p>\n","protected":false},"excerpt":{"rendered":"HCC   Hepatosel\u00fcler Karsinomda \u00a0LI-RADS Tedavi Yan\u0131t Algoritmas\u0131n\u0131n Tan\u0131sal Performans\u0131: BT ve MRG’deki Kontrastlanma Paternleriyle […]","protected":false},"author":3,"featured_media":2955,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[209],"tags":[],"class_list":["post-8218","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-tr"],"yoast_head":"\nWhat's new in Liver Imaging (Turkish) - September 2020 - ACORE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What's new in Liver Imaging (Turkish) - September 2020 - ACORE\" \/>\n<meta property=\"og:description\" content=\"HCC   Hepatosel\u00fcler Karsinomda \u00a0LI-RADS Tedavi Yan\u0131t Algoritmas\u0131n\u0131n Tan\u0131sal Performans\u0131: BT ve MRG’deki Kontrastlanma Paternleriyle […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"ACORE\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-10T10:11:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/ct-scan-workstation-with-ct-whole-abdomen-background_t20_ZVGWkj.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2030\" \/>\n\t<meta property=\"og:image:height\" content=\"1457\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Abdelrahman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Abdelrahman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/\",\"url\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/\",\"name\":\"What's new in Liver Imaging (Turkish) - September 2020 - ACORE\",\"isPartOf\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/ct-scan-workstation-with-ct-whole-abdomen-background_t20_ZVGWkj.jpg\",\"datePublished\":\"2020-09-10T10:11:06+00:00\",\"author\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#primaryimage\",\"url\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/ct-scan-workstation-with-ct-whole-abdomen-background_t20_ZVGWkj.jpg\",\"contentUrl\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/ct-scan-workstation-with-ct-whole-abdomen-background_t20_ZVGWkj.jpg\",\"width\":2030,\"height\":1457},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/staging-hub.acoredu.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What’s new in Liver Imaging (Turkish) – September 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#website\",\"url\":\"https:\/\/staging-hub.acoredu.com\/\",\"name\":\"ACORE\",\"description\":\"Radiology education for everyone, everywhere!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging-hub.acoredu.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7\",\"name\":\"Abdelrahman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g\",\"caption\":\"Abdelrahman\"},\"url\":\"https:\/\/staging-hub.acoredu.com\/tr\/author\/abdelrahman\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What's new in Liver Imaging (Turkish) - September 2020 - ACORE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/","og_locale":"tr_TR","og_type":"article","og_title":"What's new in Liver Imaging (Turkish) - September 2020 - ACORE","og_description":"HCC   Hepatosel\u00fcler Karsinomda \u00a0LI-RADS Tedavi Yan\u0131t Algoritmas\u0131n\u0131n Tan\u0131sal Performans\u0131: BT ve MRG’deki Kontrastlanma Paternleriyle […]","og_url":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/","og_site_name":"ACORE","article_published_time":"2020-09-10T10:11:06+00:00","og_image":[{"width":2030,"height":1457,"url":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/ct-scan-workstation-with-ct-whole-abdomen-background_t20_ZVGWkj.jpg","type":"image\/jpeg"}],"author":"Abdelrahman","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Abdelrahman","Tahmini okuma s\u00fcresi":"8 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/","url":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/","name":"What's new in Liver Imaging (Turkish) - September 2020 - ACORE","isPartOf":{"@id":"https:\/\/staging-hub.acoredu.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#primaryimage"},"image":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/ct-scan-workstation-with-ct-whole-abdomen-background_t20_ZVGWkj.jpg","datePublished":"2020-09-10T10:11:06+00:00","author":{"@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7"},"breadcrumb":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#primaryimage","url":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/ct-scan-workstation-with-ct-whole-abdomen-background_t20_ZVGWkj.jpg","contentUrl":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/ct-scan-workstation-with-ct-whole-abdomen-background_t20_ZVGWkj.jpg","width":2030,"height":1457},{"@type":"BreadcrumbList","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-liver-imaging-september-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staging-hub.acoredu.com\/"},{"@type":"ListItem","position":2,"name":"What’s new in Liver Imaging (Turkish) – September 2020"}]},{"@type":"WebSite","@id":"https:\/\/staging-hub.acoredu.com\/#website","url":"https:\/\/staging-hub.acoredu.com\/","name":"ACORE","description":"Radiology education for everyone, everywhere!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging-hub.acoredu.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7","name":"Abdelrahman","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g","caption":"Abdelrahman"},"url":"https:\/\/staging-hub.acoredu.com\/tr\/author\/abdelrahman\/"}]}},"_links":{"self":[{"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/posts\/8218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/comments?post=8218"}],"version-history":[{"count":1,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/posts\/8218\/revisions"}],"predecessor-version":[{"id":8220,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/posts\/8218\/revisions\/8220"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/media\/2955"}],"wp:attachment":[{"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/media?parent=8218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/categories?post=8218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/tags?post=8218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}